Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors
申请人:Jaroskova Libuse
公开号:US20070287743A1
公开(公告)日:2007-12-13
the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1 or 2;
M represents a direct bond or a C
1-3
alkyl linker optionally substituted with one or two substituents selected from C
1-4
alkyl, C
1-3
alkyloxy-C
1-4
alkyl-, hydroxy-C
1-4
alkyl-, hydroxy, C
1-3
alkyloxy- or phenyl-C
1-4
alkyl-;
R
1
and R
2
each independently represent hydrogen, halo, cyano, hydroxy, C
1-4
alkyl optionally substituted with halo,
C
1-4
alkyloxy-optionally substituted with one or where possible two or three substituents selected from hydroxy, Ar
1
and halo;
R
3
represents hydrogen, halo, C
1-4
alkyl, C
1-4
alkyloxy-, cyano or hydroxy;
R
4
represents hydrogen, halo, C
1-4
alkyl, hydroxy, cyano or C
1-4
alkyloxy-optionally substituted with one or where possible two or three substituents selected from hydroxy and halo;
R
5
represents hydrogen, C
1-4
alkyl or Ar
2
—C
1-4
alkyl-;
R
6
represents hydrogen, hydroxy, halo, C
1-4
alkyl or C
1-4
alkyoxy-;
R
7
represents hydrogen or R
7
and R
5
taken together with the carbon atom to which they are attached from a —C
2
-alkyl-linker;
Ar
1
and Ar
2
each independently represent phenyl or naphtyl wherein said phenyl and naphtyl are optionally substituted with C
1-4
alkyl, C
1-4
alkyloxy-, or phenyl-C
1-4
alkyl.